BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35391788)

  • 21. Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy.
    de Wit NM; Snkhchyan H; den Hoedt S; Wattimena D; de Vos R; Mulder MT; Walter J; Martinez-Martinez P; Hoozemans JJ; Rozemuller AJ; de Vries HE
    J Alzheimers Dis; 2017; 60(3):795-807. PubMed ID: 27662305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.
    Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q
    Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquiritigenin Decreases Aβ Levels and Ameliorates Cognitive Decline by Regulating Microglia M1/M2 Transformation in AD Mice.
    Du Y; Luo M; Du Y; Xu M; Yao Q; Wang K; He G
    Neurotox Res; 2021 Apr; 39(2):349-358. PubMed ID: 32990912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic Change of Intracellular Metabolism of Microglia Evaluated by Transcriptomics in an Alzheimer's Mouse Model.
    Qiu H; Zhao R; Fei G; Pan X; Sang S; Xu Y; Jin B; Jin L; Cheng X; Zhong C
    J Alzheimers Dis; 2021; 81(2):517-531. PubMed ID: 33814454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer's disease.
    Liu M; Guo H; Li C; Wang D; Wu J; Wang C; Xu J; Qin RA
    BMC Complement Altern Med; 2015 Oct; 15():382. PubMed ID: 26497584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer's disease cell and mouse models for neuroprotection and cognitive improvement.
    Chiu YJ; Lin CH; Lee MC; Hsieh-Li HM; Chen CM; Wu YR; Chang KH; Lee-Chen GJ
    Aging (Albany NY); 2021 Jun; 13(11):15620-15637. PubMed ID: 34106880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
    Katsel P; Li C; Haroutunian V
    Neurochem Res; 2007; 32(4-5):845-56. PubMed ID: 17342407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
    Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
    Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
    Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
    J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
    Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
    Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer's disease expressing APOE4.
    Crivelli SM; Luo Q; Kruining DV; Giovagnoni C; Mané-Damas M; den Hoedt S; Berkes D; De Vries HE; Mulder MT; Walter J; Waelkens E; Derua R; Swinnen JV; Dehairs J; Wijnands EPM; Bieberich E; Losen M; Martinez-Martinez P
    Biomed Pharmacother; 2022 Aug; 152():113240. PubMed ID: 35689862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectin-3 promotes Aβ oligomerization and Aβ toxicity in a mouse model of Alzheimer's disease.
    Tao CC; Cheng KM; Ma YL; Hsu WL; Chen YC; Fuh JL; Lee WJ; Chao CC; Lee EHY
    Cell Death Differ; 2020 Jan; 27(1):192-209. PubMed ID: 31127200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
    Lecordier S; Pons V; Rivest S; ElAli A
    Front Immunol; 2021; 12():813536. PubMed ID: 35173711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice.
    McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA
    Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
    Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
    Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
    Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deferoxamine enhances alternative activation of microglia and inhibits amyloid beta deposits in APP/PS1 mice.
    Zhang Y; He ML
    Brain Res; 2017 Dec; 1677():86-92. PubMed ID: 28963052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.